Skip to content
Subscriber Only
Business
Prognosis

China Approves Second Coronavirus Vaccine for Public Use

  • CoronaVac was previously approved only for emergency use
  • China is falling behind U.S., Europe in vaccinations
The Sinovac Biotech Ltd. coronavirus vaccine. 

The Sinovac Biotech Ltd. coronavirus vaccine. 

Photographer: Dimas Ardian/Bloomberg
By
Bloomberg News
Updated on

Sinovac Biotech Ltd. received regulatory approval from Chinese authorities for its coronavirus vaccine to be used by the general public in the country’s second such authorization.

The conditional approval was announced by the National Medical Products Administration on Saturday. Sinovac earlier said the protective efficacy of its vaccine, CoronaVac, met World Health Organization and China regulatory standards 14 days after the completion of two shots.